UBS ASSET MANAGEMENT AMERICAS LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$981,000
-44.5%
78,804
-38.9%
0.00%
-50.0%
Q3 2016$1,766,000
+83.0%
128,964
-1.3%
0.00%
+100.0%
Q2 2016$965,000
+15.4%
130,6960.0%0.00%0.0%
Q1 2016$836,000
-7.5%
130,696
-9.7%
0.00%0.0%
Q4 2015$904,000
+9.0%
144,674
+2.0%
0.00%0.0%
Q3 2015$829,000
-8.4%
141,874
+29.6%
0.00%0.0%
Q2 2015$905,000
+10.5%
109,494
+10.2%
0.00%0.0%
Q1 2015$819,000
+24.1%
99,394
+3.5%
0.00%0.0%
Q4 2014$660,000
+27.4%
95,9940.0%0.00%0.0%
Q3 2014$518,000
+3.6%
95,994
+22.3%
0.00%0.0%
Q2 2014$500,000
-33.4%
78,494
-15.7%
0.00%0.0%
Q1 2014$751,000
+23.5%
93,154
+4.5%
0.00%0.0%
Q4 2013$608,000
-98.0%
89,154
-94.5%
0.00%
-97.3%
Q3 2013$29,938,000
+30.6%
1,627,038
+24.1%
0.04%
+23.3%
Q2 2013$22,924,0001,310,7370.03%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$94,961,00026.95%
Consonance Capital Management LP 8,845,742$65,370,0009.25%
Opaleye Management Inc. 1,250,000$9,238,0006.17%
Tamarack Advisers, LP 2,100,000$15,519,0005.95%
IRONWOOD INVESTMENT MANAGEMENT LLC 293,352$2,168,0001.62%
Camber Capital Management LP 4,000,000$29,560,0001.43%
Palo Alto Investors LP 2,535,117$18,735,0001.42%
Granite Point Capital Management, L.P. 430,890$3,184,0001.37%
1492 Capital Management LLC 202,500$1,496,0001.34%
HighVista Strategies LLC 869,100$6,423,0001.23%
View complete list of ARIAD PHARMACEUTICALS INC shareholders